What are alternative treatments for acute anxiety in the absence of benzodiazepines (BZDs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alternative Treatments for Acute Anxiety Without Benzodiazepines

First-line treatment for acute anxiety when benzodiazepines are not an option should be selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs), with paroxetine being particularly effective for social anxiety disorder. 1, 2

Pharmacological Options

First-Line Medications

  • SSRIs (such as paroxetine, fluvoxamine, escitalopram) are recommended as first-line pharmacological treatment for anxiety disorders due to their efficacy and favorable side effect profile 1
  • SNRIs (such as venlafaxine, duloxetine) offer dual action on both serotonin and noradrenaline systems, which may provide advantages in certain anxiety disorders 3
  • Paroxetine has demonstrated significant superiority over placebo in treating social anxiety disorder at doses of 20-50 mg daily 2

Second-Line Medications

  • Antipsychotics may be considered for severe anxiety with agitation:

    • Haloperidol 0.5-1 mg orally at night and every 2 hours as required (maximum 10 mg daily, 5 mg in elderly) 1
    • Quetiapine 25 mg (immediate release) orally every 12 hours if needed 1
    • Olanzapine 2.5-5 mg orally or subcutaneously (caution: risk of oversedation) 1
  • Other options include:

    • Hydroxyzine (an antihistamine) has shown efficacy over placebo for generalized anxiety disorder, though evidence quality is limited 4
    • Buspirone (5-HT1A receptor partial agonist) may be effective for generalized anxiety disorder 3
    • Pregabalin has evidence for anxiety treatment and lacks the dependence potential of benzodiazepines 5

For Specific Situations

  • For anxiety in palliative care settings when benzodiazepines are contraindicated:

    • Levomepromazine (methotrimeprazine) 5-12.5 mg orally or subcutaneously every 2 hours as needed 1
    • Haloperidol in lower doses (0.25-0.5 mg) for elderly or frail patients 1
  • For breathlessness-associated anxiety:

    • Low-dose morphine may be considered (if not contraindicated): 2.5-10 mg PO every 2 hours as needed 1
    • In renal impairment (GFR <30 mL/min), use oxycodone instead of morphine 1

Non-Pharmacological Approaches

  • Cognitive Behavioral Therapy (CBT) has the highest level of evidence among psychological interventions 1, 5

  • Other effective psychological interventions include:

    • Mindfulness-based cognitive therapy 1
    • Acceptance and commitment therapy 1
    • Relaxation techniques and stress management 1
  • Physical comfort measures:

    • Use of fans and cooler temperatures for anxiety with breathlessness 1
    • Educational, psychosocial, and emotional support for the patient 1

Treatment Algorithm

  1. Assess severity and context of anxiety:

    • For mild-moderate anxiety: Start with non-pharmacological approaches
    • For moderate-severe anxiety: Consider medication plus non-pharmacological approaches 5
  2. First medication choice:

    • Start with an SSRI (paroxetine 20mg daily) or SNRI 2, 5
    • Note: These medications may take 2-4 weeks for full effect
  3. For immediate symptom relief while waiting for SSRI/SNRI effect:

    • Consider hydroxyzine 25-50mg as needed 4
    • Or low-dose antipsychotic for severe agitation (haloperidol 0.5-1mg) 1
  4. For treatment-resistant anxiety:

    • Consider augmentation with second-generation antipsychotics at low doses 1
    • Consider pregabalin as an alternative 5

Important Considerations and Pitfalls

  • Avoid NSAIDs in patients with heart failure as they increase fluid retention and risk of worsening heart failure 1

  • Caution with antipsychotics:

    • Monitor for extrapyramidal side effects, especially with haloperidol 1
    • Use lower doses in elderly patients or those with hepatic impairment 1
    • Beware of QTc prolongation with certain antipsychotics 1
  • Medication duration:

    • After remission, medications should be continued for 6-12 months to prevent relapse 5
    • For long-term treatment, regularly re-evaluate the need for continued medication 2
  • Special populations:

    • In elderly patients: Start with lower doses of all medications 1
    • In renal impairment: Avoid morphine and use oxycodone if opioids are needed 1
    • In patients with COPD: Use caution with respiratory depressants 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Serotonin noradrenaline reuptake inhibitors: A new generation of treatment for anxiety disorders.

International journal of psychiatry in clinical practice, 2006

Research

Hydroxyzine for generalised anxiety disorder.

The Cochrane database of systematic reviews, 2010

Research

Treatment of anxiety disorders.

Dialogues in clinical neuroscience, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.